Want to see TSE:CRON full AI Analyst Report?
CRON Stock Chart & Stats
C$4.95
C$0.09(2.27%)
At close: 4:00 PM EDT
C$4.95
C$0.09(2.27%)
Day’s Range― - ―
52-Week RangeC$3.23 - C$4.99
Previous CloseN/A
Volume145.76K
Average Volume (3M)128.69K
Market Cap
C$1.70B
Enterprise ValueC$410.50M
Total Cash (Recent Filing)C$797.02M
Total Debt (Recent Filing)C$1.29M
Price to Earnings (P/E)17.2
Beta1.21
Next Earnings
Nov 11, 2026EPS Estimate
0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.19
Shares Outstanding368,412,870
10 Day Avg. Volume102,448
30 Day Avg. Volume128,692
Financial Highlights & Ratios
PEG Ratio0.83
Price to Book (P/B)0.92
Price to Sales (P/S)6.74
P/FCF Ratio6.63K
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$7.00Price Target Upside41.41% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.15
Revenue Forecast (FY)C$199.00M
Bulls Say, Bears Say
Bulls Say
Revenue And EBITDA GrowthRecord quarterly growth shows stronger demand and meaningful operating leverage across the business. If this performance persists, faster gross-profit and EBITDA growth can improve internal funding capacity and support continued investment in brands, products, and international expansion.
Conservative Balance SheetExtremely low leverage gives Cronos substantial financial flexibility in a capital-intensive and regulated industry. The conservatively financed structure reduces debt-service pressure, supports resilience through uneven cannabis cycles, and leaves more capacity for growth investments or other capital allocation.
Improving Cash GenerationThe shift to positive operating and free cash flow is a material improvement in business quality because growth is increasingly supported by internally generated funds. Sustained cash generation could reduce reliance on external financing and provide flexibility for expansion, acquisitions, and shareholder returns.
Bears Say
Profitability Not Yet ProvenDespite improved revenue, gross margin, and operating results, Cronos has not yet demonstrated consistent bottom-line profitability. Continued net losses or another operating setback could weaken the durability of the turnaround, limit retained capital, and make future earnings more difficult to forecast.
Gross Margin VolatilityMargin dependence on growing conditions, market mix, and product mix creates uncertainty around earnings quality over the next several quarters. Even with strong demand, unfavorable seasonality or a lower-margin mix could reduce operating leverage and make cash generation less consistent.
Israel Regulatory RiskThe investigation introduces a structural regulatory risk in an important growth market where Cronos has delivered record results. Adverse trade measures or prolonged uncertainty could restrict market access, increase compliance costs, disrupt expansion plans, or pressure the economics of Canadian imports.
Cronos Group News
CRON FAQ
What was Cronos Group’s price range in the past 12 months?
Cronos Group lowest stock price was C$3.23 and its highest was C$4.99 in the past 12 months.
What is Cronos Group’s market cap?
Cronos Group’s market cap is C$1.70B.
When is Cronos Group’s upcoming earnings report date?
Cronos Group’s upcoming earnings report date is Nov 11, 2026 which is in 36 days.
How were Cronos Group’s earnings last quarter?
Cronos Group released its earnings results on Aug 06, 2026. The company reported C$0.128 earnings per share for the quarter, beating the consensus estimate of C$0.014 by C$0.114.
Is Cronos Group overvalued?
According to Wall Street analysts Cronos Group’s price is currently Undervalued.
Does Cronos Group pay dividends?
Cronos Group does not currently pay dividends.
What is Cronos Group’s EPS estimate?
Cronos Group’s EPS estimate is 0.04.
How many shares outstanding does Cronos Group have?
Cronos Group has 368,412,870 shares outstanding.
What happened to Cronos Group’s price movement after its last earnings report?
Cronos Group reported an EPS of C$0.128 in its last earnings report, beating expectations of C$0.014. Following the earnings report the stock price went up 13.684%.
Which hedge fund is a major shareholder of Cronos Group?
Currently, no hedge funds are holding shares in TSE:CRON
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cronos Group Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
C$7.00 (41.41% Upside)
C$7.00 (41.41% Upside)
Blogger Sentiment
Bullish
TSE:CRON Sentiment 86%
Sector Average 66%
Sector Average 66%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 2.0%
Last 30 Days ▼ 2.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
24.51%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
0.39%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Cronos Group
Cronos Group Inc. functions as a diversified global cannabinoid enterprise. Within the United States, it manufactures, promotes, and distributes a variety of hemp-derived supplements and cosmetic products. These items are available under its Lord Jones and Happy Dance brands through online sales, traditional retail, and hospitality partner networks. The company also plays a significant role in the cultivation, production, and commercialization of cannabis and cannabis-infused products for both medicinal and adult-use sectors. Its comprehensive product offerings encompass dried cannabis flower, pre-rolled joints, edibles, concentrated forms, and cannabis extracts. These are distributed via wholesale partnerships and direct-to-consumer channels, prominently featuring its wellness platform, PEACE NATURALS, and its adult-use brand, Spinach. Moreover, Cronos Group exports dried cannabis and cannabis oils to international markets including Germany, Israel, and Australia. Established in 2012, the company maintains its corporate headquarters in Toronto, Canada.
CRON Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a broadly positive operational and financial picture: record revenue, gross profit, and adjusted EBITDA, strong brand performance (notably Spinach), meaningful international growth (Israel and Germany), and a robust cash position. Key risks and headwinds include a new anti-dumping investigation in Israel, modest OpEx increases, margin variability tied to seasonality and mix, and timing uncertainty around the CanAdelaar closing. On balance, the positive operational momentum and strong financials outweigh the highlighted risks.View all TSE:CRON earnings summariesCRON Stock 12 Month Forecast
Average Price Target
C$7.00
▲(41.41% Upside)